Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

NCT03432676 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Incyte (supporter of the study) is no longer going to support the study.

Conditions

ATM Gene Mutation
Deleterious BRCA1 Gene Mutation
Deleterious BRCA2 Gene Mutation
Homologous Recombination Deficiency
Pancreatic Ductal Adenocarcinoma
Stage II Pancreatic Cancer AJCC v8
Stage IIA Pancreatic Cancer AJCC v8
Stage IIB Pancreatic Cancer AJCC v8
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8

Interventions

DRUG: Epacadostat
BIOLOGICAL: Pembrolizumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]